Appointment booking for Dr. Charles Galea, MD is currently not available.Dr. Charles Galea, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Charles Galea, MD (he/him) is a Rheumatologist in Waycross, GA with over 19 years of experience. What is your opinion of Dr. Charles Galea, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Charles Galea, MD has received over $22,669 which includes payments from the following companies:
$2,581.45 from Amgen Inc.
$2,306.85 from Genentech USA, Inc.
$2,109.10 from UCB, Inc.
$1,836.35 from Janssen Biotech, Inc.
$1,721.21 from Pfizer Inc.
$1,562.16 from AbbVie, Inc.
$1,391.80 from GlaxoSmithKline, LLC.
$834.71 from Celgene Corporation
$789.98 from Horizon Pharma plc
$727.23 from Novartis Pharmaceuticals Corporation
$691.75 from E.R. Squibb & Sons, L.L.C.
$642.19 from Mallinckrodt LLC
$638.13 from LILLY USA, LLC
$553.69 from Purdue Pharma L.P.
$474.97 from Radius Health, Inc.
$406.59 from GENZYME CORPORATION
$400.00 from COMSORT, Inc
$373.28 from Janssen Scientific Affairs, LLC
$197.28 from Upsher-Smith Laboratories Inc.
$188.84 from Mallinckrodt Enterprises LLC
Payments received by Dr. Charles Galea, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!